3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Urinary Tract Infections
1
Thrombocytopenia
1
Staphylococcal Infections
1
Spasm
1
Sleep Initiation and Maintenance Disorders
1
Sepsis
1
Seizures
1
Schizophrenia, Treatment-Resistant
1
Schizophrenia
1
Retinitis
1
Renal Insufficiency, Chronic
1
Pulmonary Arterial Hypertension
1
Pneumonia
1
Pain
1
Neutropenia
1
Migraine Disorders
1
Menorrhagia
1
Meningitis, Bacterial
1
Meningitis
1
Intraabdominal Infections
1
Influenza, Human
1
Inflammation
1
Infections
1
Hypokalemia
1
Hypertension
1
Hyperaldosteronism
1
Herpes Simplex
1
Hemophilia A
1
Hematologic Neoplasms
1
Hemangioma, Capillary
1
Interventions
Cyclophosphamide
72
fludarabine
65
Tacrolimus
43
fludarabine phosphate
40
Whole-Body Irradiation
37
Mycophenolic Acid
35
Busulfan
32
Melphalan
28
Antilymphocyte Serum
23
thymoglobulin
22
Thiotepa
20
Methotrexate
20
Standard of Care
19
Stem Cell Transplantation
17
Practice Guidelines as Topic
17
Granulocyte Colony-Stimulating Factor
17
Rituximab
15
Surveys and Questionnaires
12
Sirolimus
12
Filgrastim
12
Interviews as Topic
11
Cyclosporine
11
Blood Specimen Collection
11
Peripheral Blood Stem Cell Transplantation
10
Exercise
10
venetoclax
9
Mesna
9
Cytarabine
9
Bortezomib
9
Hematopoietic Stem Cell Transplantation
8
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Hematologic Neoplasms
×
Aminocaproic Acid
×
Clear all
NCT02074436
2022-07-19
PROBLEMA
Emory University
Phase 2
Terminated
29 enrolled
10 charts